4.31
price up icon2.62%   0.11
after-market 시간 외 거래: 4.15 -0.16 -3.71%
loading

Lantern Pharma Inc 주식(LTRN)의 최신 뉴스

pulisher
09:36 AM

Sentiment analysis tools applied to Lantern Pharma Inc.July 2025 Gainers & Weekly Breakout Opportunity Watchlist - Newser

09:36 AM
pulisher
05:17 AM

How liquid is Lantern Pharma Inc. stockJuly 2025 Volume & Weekly Return Optimization Plans - خودرو بانک

05:17 AM
pulisher
04:04 AM

Can Lantern Pharma Inc. disrupt its industryQuarterly Portfolio Summary & High Accuracy Swing Trade Signals - خودرو بانک

04:04 AM
pulisher
02:47 AM

Can Lantern Pharma Inc. grow without dilution2025 Retail Activity & Stock Portfolio Risk Management - 더경남뉴스

02:47 AM
pulisher
Sep 05, 2025

Is Lantern Pharma Inc. stock trending bullishPortfolio Performance Summary & Verified Momentum Stock Watchlist - خودرو بانک

Sep 05, 2025
pulisher
Sep 05, 2025

Lantern Pharma Inc. stock volume spike explainedTrade Risk Assessment & AI Powered Market Entry Ideas - Newser

Sep 05, 2025
pulisher
Sep 05, 2025

Lantern Pharma Inc. stock chart pattern explained2025 Fundamental Recap & High Accuracy Investment Signals - Newser

Sep 05, 2025
pulisher
Sep 05, 2025

Can Lantern Pharma Inc. lead its sector in growthQuarterly Trade Summary & AI Enhanced Execution Alerts - خودرو بانک

Sep 05, 2025
pulisher
Sep 05, 2025

Hoth Therapeutics shares fall 2.24% premarket after adopting Lantern Pharma's AI-driven drug development tool. - AInvest

Sep 05, 2025
pulisher
Sep 05, 2025

How sentiment analysis helps forecast Lantern Pharma Inc.Portfolio Return Report & Growth-Oriented Investment Plans - Newser

Sep 05, 2025
pulisher
Sep 04, 2025

Using data tools to time your Lantern Pharma Inc. exitJuly 2025 Reactions & High Accuracy Investment Signals - Newser

Sep 04, 2025
pulisher
Sep 04, 2025

Hoth Therapeutics shares fall 1.49% after-hours after adopting Lantern Pharma's AI-driven drug development tool. - AInvest

Sep 04, 2025
pulisher
Sep 04, 2025

Lantern Pharma (NASDAQ: LTRN) Completes FDA Type C Meeting, Gains Guidance for Planned Pediatric CNS Cancer Trial - The Globe and Mail

Sep 04, 2025
pulisher
Sep 04, 2025

Lantern Pharma shares fall 1.52% intraday after FDA meeting and Hoth Therapeutics partnership. - AInvest

Sep 04, 2025
pulisher
Sep 04, 2025

AI-Driven Drug Development: Hoth Therapeutics and Lantern Pharma’s Strategic Partnership to Revolutionize CNS Therapies - AInvest

Sep 04, 2025
pulisher
Sep 04, 2025

Lantern Pharma's PredictBBB.ai Platform to Drive Next-Gen Drug Development with Hoth Therapeutics Partnership - AInvest

Sep 04, 2025
pulisher
Sep 04, 2025

94% Accurate AI Platform: Hoth Therapeutics Taps Revolutionary Blood-Brain Barrier Prediction Technology - Stock Titan

Sep 04, 2025
pulisher
Sep 04, 2025

Detecting support and resistance levels for Lantern Pharma Inc.CEO Change & Smart Swing Trading Alerts - Newser

Sep 04, 2025
pulisher
Sep 04, 2025

What data driven models say about Lantern Pharma Inc.’s future2025 Breakouts & Breakdowns & Safe Entry Zone Identification - Newser

Sep 04, 2025
pulisher
Sep 04, 2025

Will breakout in Lantern Pharma Inc. lead to full recoveryBear Alert & Fast Moving Stock Trade Plans - Newser

Sep 04, 2025
pulisher
Sep 03, 2025

Lantern Pharma Receives FDA Guidance for Pediatric CNS Cancer Trial of AI-Discovered Therapy - citybuzz -

Sep 03, 2025
pulisher
Sep 03, 2025

Automated trading signals detected on Lantern Pharma Inc.Market Movement Recap & Detailed Earnings Play Alerts - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

Lantern Pharma receives FDA feedback on pediatric brain cancer trial - Investing.com

Sep 03, 2025
pulisher
Sep 03, 2025

Lantern Pharma Completes FDA Type C Meeting, Advances Pediatric CNS Cancer Trial with FDA Guidance - AInvest

Sep 03, 2025
pulisher
Sep 03, 2025

Lantern Pharma Announces Completion of Type C Meeting with FDA, Providing Clarity on Regulatory Pathway for Pediatric CNS Cancer Trial - Business Wire

Sep 03, 2025
pulisher
Sep 03, 2025

Top chart patterns to watch in Lantern Pharma Inc.July 2025 Review & Daily Chart Pattern Signals - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

What is Lantern Pharma Inc.’s book value per shareWeekly Profit Report & Risk Controlled Daily Trade Plans - خودرو بانک

Sep 03, 2025
pulisher
Sep 03, 2025

How high can Lantern Pharma Inc. stock goMarket Sentiment Summary & Daily Profit Focused Stock Screening - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

Market reaction to Lantern Pharma Inc.’s recent newsWeekly Stock Analysis & Risk Managed Investment Strategies - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

How to integrate Lantern Pharma Inc. into portfolio analysis toolsJuly 2025 Weekly Recap & Fast Gain Stock Trading Tips - Newser

Sep 03, 2025
pulisher
Sep 02, 2025

Will Lantern Pharma Inc. price bounce be sustainableWeekly Trade Analysis & Low Risk High Reward Trade Ideas - Newser

Sep 02, 2025
pulisher
Sep 02, 2025

What machine learning models say about Lantern Pharma Inc.Fed Meeting & Accurate Entry/Exit Alerts - Newser

Sep 02, 2025
pulisher
Sep 02, 2025

Does Lantern Pharma Inc. show high probability of reboundJuly 2025 Levels & Weekly High Return Opportunities - Newser

Sep 02, 2025
pulisher
Sep 02, 2025

Is Lantern Pharma Inc. a cyclical or defensive stock2025 Market Trends & Weekly Market Pulse Alerts - خودرو بانک

Sep 02, 2025
pulisher
Sep 02, 2025

Custom strategy builders for tracking Lantern Pharma Inc.Weekly Trend Summary & Target Return Focused Picks - Newser

Sep 02, 2025
pulisher
Sep 02, 2025

Is Lantern Pharma Inc. vulnerable to short sellersBond Market & Low Volatility Stock Recommendations - خودرو بانک

Sep 02, 2025
pulisher
Sep 02, 2025

Does Lantern Pharma Inc. align with a passive investing strategyJuly 2025 Opening Moves & Weekly Chart Analysis and Trade Guides - خودرو بانک

Sep 02, 2025
pulisher
Sep 01, 2025

Using Bollinger Bands to evaluate Lantern Pharma Inc.M&A Rumor & Stock Portfolio Risk Control - Newser

Sep 01, 2025
pulisher
Sep 01, 2025

Can Lantern Pharma Inc. reach resistance levels soon2025 Market Trends & Fast Gaining Stock Strategy Reports - خودرو بانک

Sep 01, 2025
pulisher
Sep 01, 2025

RedChip to Host Exclusive Investor Webinar Featuring Lantern Pharma on August 26 - The Florida Times-Union

Sep 01, 2025
$86.64
price up icon 1.40%
$27.54
price up icon 0.58%
$25.98
price up icon 9.16%
$112.46
price up icon 8.66%
$145.10
price up icon 1.80%
biotechnology ONC
$341.80
price up icon 7.24%
자본화:     |  볼륨(24시간):